<DOC>
	<DOCNO>NCT01818310</DOCNO>
	<brief_summary>The aim present clinical trial evaluate hypothesis , BMAC prepare bone marrow aspirate inject intramuscularly ischemic area low extremity patient diabetes mellitus type II. , intraarterially defect limb intravenous application , great potential improve perfusion ischemic limbs standard treatment NO-CLI . Another aim study find difference among three different therapeutic type BMAC application , define effectiveness safety compare impact different mean application speed heal limb defect improvement perfusion parameter .</brief_summary>
	<brief_title>Safety Efficacy Study Autologous Bone Marrow Aspirate Concentrate No-Option Critical Limb Ischemia</brief_title>
	<detailed_description>Secondary hypothesis assumes , intravenous application BMAC patient T2DM old 30 year age , dose insulin exceed 0.7 U/kg/day 50U/day result decrease insulin dose course 6-month follow-up improvement glycHBA1c level , improvement liver kidney function , decrease cholesterol level improvement immune response parameter , i.e . parameter lymphocytar blastic transformation , case patient intramuscular intraarterial application BMAC .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<criteria>type 2 diabetes mellitus diagnosis critical limb ischemia nonhealing defect study limb ABI value &lt; 50 mmHg ABI &lt; 0.4 TBI value &lt; 40 mmHg TBI &lt; 0.4 TcPO2 &lt; 20 mmHg supine position suitable surgical revascularization procedure age &gt; 18 year sign Informed Consent nonsigning Informed Consent anticipate life expectancy &lt; 6 month history bonemarrow disease renal failure dialysis dependency know malignant disease health risk exclude possibility general anaesthesia sedation lifethreatening ischaemic heart disease vast necrosis index limb active infectious disease , ATB treatment treatment immunosupressives pregnancy , breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>ischemia</keyword>
	<keyword>diabetes mellitus</keyword>
	<keyword>bone marrow aspirate concentrate ( BMAC )</keyword>
</DOC>